SRTS - センサス・ヘルスケア (Sensus Healthcare Inc.) センサス・ヘルスケア

 SRTSのチャート


 SRTSの企業情報

symbol SRTS
会社名 Sensus Healthcare Inc (センサス・ヘルスケア)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   IT・通信(IT_Communications)
概要 事業概要 Sensus Healthcare Inc. formerly Sensus Healthcare LLC is a manufacturer of superficial radiation therapy devices. The Company designs manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions such as keloids with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The Company''s product the SRT-100 is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions such as the fold in the nose eyelids lips corner of the mouth and the lining of the ear.   センサス・ヘルスケアは米国の医療機器メ―カ―。非メラノ―マ性皮膚がんや、その他の皮膚疾患治療に焦点を当てた医療用装置を開発する。同社の「SRT-100」は、皮膚表面への放射線治療を可能とし、外科手術の代替法として、基底細胞がんや有棘細胞がん、ケロイドなどの治療に利用される。本社はフロリダ州ボカラトン。   Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. The Sculptura™ modulated robotic brachytherapy radiation oncology system provides targeted Directional Anisotropic Radiation Therapy (ART) and Brachytherapy utilizing its proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently. Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.
本社所在地 851 Broken Sound Pkwy. NW #215 Boca Raton FL 33487 USA
代表者氏名 Joseph C. Sardano ジョセフ・C・サルダノ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 561-922-5808
設立年月日 40299
市場名 NASDAQ Small Cap
ipoyear 2016年
従業員数
url www.sensushealthcare.com
nasdaq_url https://www.nasdaq.com/symbol/srts
adr_tso
EBITDA EBITDA(百万ドル) -2.54865
終値(lastsale) 7.99
時価総額(marketcap) 108254089.03
時価総額 時価総額(百万ドル) 88.54073
売上高 売上高(百万ドル) 23.27752
企業価値(EV) 企業価値(EV)(百万ドル) 84.74358
当期純利益 当期純利益(百万ドル) -3.04083
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Sensus Healthcare Inc revenues increased 29% to $12M. Net loss decreased 29% to $1.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Advertising Expense decrease of 21% to $832K (expense) Interest income increase of 12% to $46K (income).

 SRTSのテクニカル分析


 SRTSのニュース

   Sensus Healthcare Consensus Indicates Potential 31.8% Upside  2021/06/23 11:29:19 DirectorsTalk
Sensus Healthcare with ticker code (SRTS) have now 6 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 6 and 2.95 calculating the mean target price we have 4.43. Given that the stocks previous close was at 3.36 this now indicates there is a potential upside of 31.8%. The 50 day MA is 3.13 and the 200 moving average now moves to 2.9. The company has a market capitalisation of $57m. Find out more information at: /> [stock_market_widget type="chart" symbol="SRTS" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Sensus Healthcare manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
   Is Sensus Healthcare, Inc. (SRTS) A Good Stock To Buy?  2021/06/15 19:23:24 Insider Monkey
   Sensus Healthcare (SRTS) Gets a Buy Rating from Northland Securities  2021/06/15 11:10:25 Smarter Analyst
In a report released today, James Terwilliger from Northland Securities maintained a Buy rating on Sensus Healthcare (SRTS), with a price target of The post Sensus Healthcare (SRTS) Gets a Buy Rating from Northland Securities appeared first on Smarter Analyst .
   Global Intraoperative Radiation Therapy Market Growth Potential In The Future iCAD, Inc., Eckert & Ziegler, Elekta, GMV Innovating Solutions, Sensus Healthcare  2021/06/14 16:38:33 OpenPR
The proposed Intraoperative Radiation Therapy Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes
   Sensus Healthcare Inc. Shares Close the Day 19.6% Higher - Daily Wrap  2021/02/26 22:30:00 Kwhen Finance
Sensus Healthcare Inc. shares closed today 19.6% higher than it did at the end of yesterday. The stock is currently up 18.4% year-to-date, up 12.6% over the past 12 months, and down 21.9% over the past five years. Today, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.5%. Trading Activity Shares traded as high as $6.09 and as low as $3.60 this week.Shares closed 2e+1% below its 52-week high and 2e+2% above its 52-week low.Trading volume this week was 93.0% lower than the 10-day average and 80.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 11.9% higher than its 5-day moving average, 13.3% higher than its 20-day moving average, and 30.4% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 225.7% The company's stock price performance over the past 12 months lags the peer average by -84.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   48 Stocks Moving In Friday's Mid-Day Session - Stocks News Feed  2021/02/26 17:09:02 Stocks News Feed
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 52.8% to $5.76. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. Sensus Healthcare, Inc. (NASDAQ: SRTS) surged 45% to $5.52 after the company reported Q4 results. Just Energy Group Inc. (NYSE:… Read More »48 Stocks Moving In Friday’s Mid-Day Session
   Keloid Treatment Market to See Fabulous Rise by 2027 with Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc. | FMI Report  2021/02/16 17:54:48 OpenPR
According to the latest market report published by FMI titled‘Keloid Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),’the global keloid treatment market is estimated to be worth US$ 3,145.8 Mn by 2017 end, and is expected to expand
   Sensus Healthcare Reports Third Quarter 2020 Financial Results  2020/11/05 21:02:00 GlobeNewswire
Conference call begins at 4:30 p.m. Eastern time today
   Sensus Healthcare Reports Second Quarter 2020 Financial Results  2020/08/06 20:02:00 GlobeNewswire
Conference call begins at 4:30 p.m. Eastern time today
   Sensus Healthcare to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 6, 2020  2020/07/30 12:30:00 GlobeNewswire
BOCA RATON, Fla. , July 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,…
   48 Stocks Moving In Friday's Mid-Day Session - Stocks News Feed  2021/02/26 17:09:02 Stocks News Feed
Gainers Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 52.8% to $5.76. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. Sensus Healthcare, Inc. (NASDAQ: SRTS) surged 45% to $5.52 after the company reported Q4 results. Just Energy Group Inc. (NYSE:… Read More »48 Stocks Moving In Friday’s Mid-Day Session
   Keloid Treatment Market to See Fabulous Rise by 2027 with Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc. | FMI Report  2021/02/16 17:54:48 OpenPR
According to the latest market report published by FMI titled‘Keloid Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),’the global keloid treatment market is estimated to be worth US$ 3,145.8 Mn by 2017 end, and is expected to expand
   Sensus Healthcare Reports Third Quarter 2020 Financial Results  2020/11/05 21:02:00 GlobeNewswire
Conference call begins at 4:30 p.m. Eastern time today
   Sensus Healthcare Reports Second Quarter 2020 Financial Results  2020/08/06 20:02:00 GlobeNewswire
Conference call begins at 4:30 p.m. Eastern time today
   Sensus Healthcare to Host Second Quarter 2020 Financial Results and Business Update Conference Call on August 6, 2020  2020/07/30 12:30:00 GlobeNewswire
BOCA RATON, Fla. , July 30, 2020 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective,…

 関連キーワード  (先端医療機器_テクノロジ― 米国株 センサス・ヘルスケア SRTS Sensus Healthcare Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)